Ticker

Continued organic quarter over quarter revenue growth with growth of over 30% from Q3 to Q4 2025 (from $529,123 in Q3 2025 to $697,340 for Q4 2025) Earnings per share for Q4, 2025: ($0. 10) per share. Annual Revenues of $1. 739 million in FY2025 Announced signed in-network contracts and credentialing with several major U.

Rocket Doctor Inc. has been selected for the prestigious Canadian Life Sciences Trade Mission to New York and New Jersey, taking place May 11-14, 2026The mission provides an opportunity to engage directly with one of the world's largest life sciences markets, comprising more than 5,100 companies and 150,000 industry professionals across the New York City metro region.

Vancouver, BC, April 17, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI") announces that, subject to regulatory approval, it has entered into an addendum to the agreement originally entered into on July 18, 2025, to further engage the services of 45 Degrees, Inc.

Maryland operations advancing with first patients seen following recent Medicaid and Medicare in-network expansion Dr. Suzanne Caccamese has been appointed Maryland Medical Lead, bringing clinical training from Penn State College of Medicine and academic and clinical leadership experience from Towson University, MedStar and the University of MarylandThe expansion underscores Rocket Doctor's U.